Total planned funding: $122,463,823
Allocations
Countries/Regions
| Asia Regional Program | $122,463,823 |
Organizational Types
| Own Agency | $41,374,161 |
| NGO | $35,895,705 |
| Unknown | $12,491,344 |
| Host Country Government Agency | $11,984,278 |
| University | $10,679,615 |
| Multi-lateral Agency | $5,960,608 |
| Private Contractor | $3,460,112 |
| Other USG Agency | $610,000 |
| Implementing Agency | $8,000 |
Program Areas
| Governance and Systems | $30,173,230 |
| Treatment | $25,519,560 |
| Management and Operations | $22,701,037 |
| Prevention | $19,842,631 |
| Testing | $13,777,970 |
| Care | $10,449,395 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $25,021,201 |
| HVMS: Management and Operations | $22,701,037 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $16,978,579 |
| HVCT: Testing: HIV Testing and Counseling | $13,777,970 |
| OHSS: Health Systems Strengthening | $13,566,045 |
| HVSI: Strategic Information | $12,493,349 |
| HBHC: Care: Adult Care and Support | $7,751,351 |
| HLAB: Laboratory Infrastructure | $4,113,836 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,037,861 |
| HKID: Care: Orphans and Vulnerable Children | $1,244,726 |
| PDCS: Care: Pediatric Care and Support | $799,959 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $769,641 |
| HVTB: Care: TB/HIV | $653,359 |
| PDTX: Treatment: Pediatric Treatment | $322,859 |
| HTXD: Treatment: ARV Drugs | $175,500 |
| HMBL: Biomedical Prevention: Blood Safety | $56,550 |
Top Partner Programs
U.S. Centers for Disease Control and Prevention:
$25,487,999
Countries/Regions
Asia Regional Program
| 2013 | $7,070,000 |
| 2014 | $6,980,000 |
| 2020 | $11,437,999 |
Not Available:
$9,905,163
Countries/Regions
Asia Regional Program
| 2013 | $0 |
| 2014 | $4,053,520 |
| 2017 | $308,157 |
| 2020 | $5,543,486 |
U.S. Agency for International Development:
$7,656,412
Countries/Regions
Asia Regional Program
| 2013 | $1,015,733 |
| 2014 | $1,060,480 |
| 2020 | $5,580,199 |